Font Size

placeholder

Ebooks: An Introduction to CAR T-Cell Production and New Developments in Immunotherapy

Custom Publishing from The Scientist and GEN, sponsored by PHC Corporation of North America


CAR T-cell production and immunotherapy are critical components in clinical medicine where reproducibility in cell culture incubator environments is essential. From media preparation to incubation and long-term storage of clinical specimens PHCbi brand products play a part before and after clinical protocols. Learn more about CAR T-cell production and cell culture in immunotherapy in two collaborative reports. Choose either or both.

  • The Scientist and PHC Corporation of North America
  • Genetic Engineering News and PHC Corporation of North America

Download the Ebooks

CAR T-Cell Ebook

About PHC Corporation of North America
PHC Corporation of North America is a subsidiary of PHC Holdings Corporation, Tokyo, Japan, a global leader in development, design and manufacturing of laboratory equipment for biopharmaceutical, life sciences, academic, healthcare and government markets. For more information, call PHC Corporation of North America at 800-858-8442, email info@us.phchd.com or visit https://www.phchd.com/us/biomedical.
© Corporation of North America

Font Size
Back